Page 115 - The Indian Optician Digital Edition September-October 2021

TABLE 1 - MUCORMYCOSIS INFECTIONS AND TOXICOLOGICAL IMPACT ON OCULAR SURFACE
AREA AND CORNEAL MANIFESTATION OF COVID-19 PANDEMIC

Location Sample Age mean/ Diagnosis Type Durations Study
Ocular median and between
Surface Area years COVID-19
and Corneal symptoms/
Manifestation diagnosis with
ophthalmic
symptoms
India 11/127 38.8 median Conjunctival Retrospective Mean 9.4 in Sindhuja
congestion, cross-sectional one et al
lid edema,
hyperaemia

India 1 65 Folicular Case 32 Nayak
Conjuctivitis et al

India 2 38 (mean) Conjuctivitis Case Initial Goel et al

who are on immunosuppressive drugs for government of India is requested to
cancer treatment, organ transplantation, or allocate sufficient funding to achieve the
other such conditions, are other groups that desired goals
are vulnerable to a severe fungal ophthalmic REFERENCES:
disease. 3
1. Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical
The triad of severe acute respiratory profile and prevalence of conjunctivitis in mild
syndrome Coronavirus-2 (SARS-CoV-2), COVID-19 patients in a tertiary care COVID-19
corticosteroid use, and uncontrolled diabetes hospital: A retrospective cross-sectional
have been evident for significant increase in study. Indian Journal of Ophthalmology. 2020
the incidence of angio-invasive maxillofacial Aug;68(8):1546.
mucormycosis. 2. Beigel JH, Tomashek KM, Dodd LE, Mehta
AK, Zingman BS, Kalil AC, Hohmann E, Chu
Additionally, there is an increased presence of HY, Luetkemeyer A, Kline S, Lopez de Castilla
fungal spores on the surface of the damp walls D. Remdesivir for the treatment of Covid-19.
of houses and in the air that humans breathe New England Journal of Medicine. 2020 Nov
and this is likely to further complicate the 5;383(19):1813-26.
situation in the coming weeks. Probable, surge 3. Tejwani S, Angmo D, Nayak BK, Sharma
of the third wave of Covid-19 in India is likely N, Sachdev MS, Dada T, Sinha R. Preferred
to affect more badly children below 18 years of practice guidelines for glaucoma management
age, and lactating mothers’ population who, during COVID-19 pandemic. Indian Journal of
unfortunately, have yet to receive vaccination. Ophthalmology. 2020 Jul;68(7):1277.
In conclusion, the present pandemic 4. Arora R, Goel R, Kumar S, Chhabra M, Saxena
situation warrants the development of S, Manchanda V, Pumma P. Evaluation of
SARS-CoV-2 in tears of patients with moderate
management protocols and to draft appropriate to severe COVID-19. Ophthalmology. 2021 Apr
guidelines for the proper control of eye diseases 1;128(4):494-503.
like conjunctivitis, endophthalmitis, orbital 5. Sheth JU, Narayanan R, Goyal J, Goyal V.
4
cellulitis, retinal vein occlusion, etc. (see Table Retinal vein occlusion in COVID-19: A novel
4-5
1). The need of the hour is to develop a risk- entity. Indian Journal of Ophthalmology. 2020
based approach (RBA) for patients and the Oct;68(10):2291.

111 | MUCORMYCOSIS